ATE149840T1 - Behandlung von leberkrebs - Google Patents

Behandlung von leberkrebs

Info

Publication number
ATE149840T1
ATE149840T1 AT92911903T AT92911903T ATE149840T1 AT E149840 T1 ATE149840 T1 AT E149840T1 AT 92911903 T AT92911903 T AT 92911903T AT 92911903 T AT92911903 T AT 92911903T AT E149840 T1 ATE149840 T1 AT E149840T1
Authority
AT
Austria
Prior art keywords
liver cancer
treatment
subject
effective amount
therapeutically effective
Prior art date
Application number
AT92911903T
Other languages
English (en)
Inventor
Arthur E Bodgen
David H Coy
Sun Hyuk Kim
Jacques-Pierre Moreau
Original Assignee
Biomeasure Inc
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc, Univ Tulane filed Critical Biomeasure Inc
Application granted granted Critical
Publication of ATE149840T1 publication Critical patent/ATE149840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92911903T 1991-05-10 1992-05-11 Behandlung von leberkrebs ATE149840T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/698,681 US6083915A (en) 1991-05-10 1991-05-10 Method for treating liver cancer

Publications (1)

Publication Number Publication Date
ATE149840T1 true ATE149840T1 (de) 1997-03-15

Family

ID=24806255

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911903T ATE149840T1 (de) 1991-05-10 1992-05-11 Behandlung von leberkrebs

Country Status (12)

Country Link
US (1) US6083915A (de)
EP (1) EP0588873B1 (de)
JP (2) JP3514754B2 (de)
AT (1) ATE149840T1 (de)
CA (1) CA2109206A1 (de)
DE (1) DE69218200T2 (de)
DK (1) DK0588873T3 (de)
ES (1) ES2101100T3 (de)
GR (1) GR3023645T3 (de)
HK (1) HK1006947A1 (de)
IE (1) IE921508A1 (de)
WO (1) WO1992020363A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100410274C (zh) * 2006-04-21 2008-08-13 暨南大学 特异性抗人肝癌噬菌体单链抗体HscFv 4－16基因及其应用
KR100814118B1 (ko) * 2006-10-17 2008-03-18 (주)국광플랜 문자나 도형 광고용 간판
KR100814120B1 (ko) * 2006-10-17 2008-03-18 (주)국광플랜 측광 및 후광을 이용한 문자나 도형 광고용 간판
EA200901142A1 (ru) * 2007-03-01 2010-04-30 Байер Шеринг Фарма Акциенгезельшафт 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
KR101642363B1 (ko) 2008-06-12 2016-07-25 입센 바이오이노베이션 리미티드 신경내분비계 질환의 억제
CN102083451A (zh) 2008-06-12 2011-06-01 赛恩泰新公司 癌症的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (de) 2008-12-18 2010-06-23 University Of Miami Polypeptide Bombesinantagonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
CA2042027A1 (en) * 1989-09-15 1991-03-16 Arthur E. Bogden Treatment of colon cancer

Also Published As

Publication number Publication date
US6083915A (en) 2000-07-04
ES2101100T3 (es) 1997-07-01
DK0588873T3 (da) 1997-09-15
DE69218200T2 (de) 1997-09-25
JP3514754B2 (ja) 2004-03-31
EP0588873A4 (de) 1995-01-11
CA2109206A1 (en) 1992-11-11
EP0588873A1 (de) 1994-03-30
IE921508A1 (en) 1992-11-18
JPH06507633A (ja) 1994-09-01
JP2004002331A (ja) 2004-01-08
HK1006947A1 (en) 1999-03-26
DE69218200D1 (de) 1997-04-17
GR3023645T3 (en) 1997-08-29
EP0588873B1 (de) 1997-03-12
WO1992020363A1 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3888378D1 (de) Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE3587741D1 (de) Behandlung von Hautkrankheiten.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
DE68907423D1 (de) Behandlung der akne.
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
DE69302439D1 (de) Topisches Präparat zur Verhütung oder Behandlung der Akne Vulgaris
ATE149840T1 (de) Behandlung von leberkrebs
SE9601395D0 (sv) New therapeutic treatment 1
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE293972T1 (de) Behandlung von chronischen schmerzen
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
CA2103708A1 (en) Treatment of ovarian cancer
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee